Skip to main content
logo
Guided Therapeutics, Inc. (GTHP)
OTCMKTS · Delayed Price · Currency is USD
0.3000
0.00 (0.00%)
At close: Jul 31, 2026

Guided Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2947108158
Market Cap Growth
70.48%376.20%17.63%-43.03%84.30%101.40%
Enterprise Value
325015131817
Last Close Price
0.300.540.150.150.300.58

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
37.7660.661395.6684.751121.4497.66
PB Ratio
-5.60-7.75-2.00-2.18-5.06-1.45

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
41.8465.812134.23129.381364.13210.72

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.54-0.49-0.44-0.51-0.78-0.53
Net Debt / Equity Ratio
-0.47-0.48-0.36-0.360.02-0.41
Net Debt / EBITDA Ratio
-1.07-1.22-0.84-0.500.02-0.96
Net Debt / FCF Ratio
-1.78-2.69-1.58-0.780.03-1.40
Asset Turnover
0.600.570.010.040.010.05
Inventory Turnover
0.360.360.010.110.140.10
Quick Ratio
0.060.010.060.120.480.12
Current Ratio
0.150.090.190.290.620.29
Return on Assets (ROA)
-109.88%-109.73%-86.48%-67.47%-77.07%-87.09%
Return on Capital Employed (ROCE)
51.90%44.70%44.10%86.60%221.80%64.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-13.45%-6.87%-24.74%-42.01%-29.78%-26.17%
FCF Yield
-4.68%-2.30%-11.45%-21.02%-10.36%-20.30%
Buyback Yield / Dilution
-37.59%-36.75%-12.14%-57.30%-142.99%-24.24%